How Jonathan Van-Tam won the nation’s trust on coronavirus | Health policy | The Guardian

Wryly ebullient deputy chief medical officer now seems to be TV’s ‘scientist of choice’

VIROLOGYCONSULT.COM

Virology, antivirals and vaccines

Who are we?

65,439,636
Confirmed cases
Updated on 3rd December 2020 10:33 pm
1,509,848
Total deaths
Updated on 3rd December 2020 10:33 pm
44,822,761
Total recovered
Updated on 3rd December 2020 10:33 pm
19,107,027
Total active cases
Updated on 3rd December 2020 10:33 pm

How Jonathan Van-Tam won the nation’s trust on coronavirus | Health policy | The Guardian

Wryly ebullient deputy chief medical officer now seems to be TV’s ‘scientist of choice’

UK approves Pfizer-BioNTech COVID-19 vaccine, first in the world | Reuters

Britain on Wednesday became the first western country to approve a COVID-19 vaccine, jumping ahead of the United States and Europe after its regulator cleared a shot developed by Pfizer for emergency use in record time.

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 | bioRxiv

bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution

Most adults over 50 say they’ll get a COVID vaccine

Most—but not all—older adults will get a COVID-19 vaccine once it's available. Many want to wait and see how others fare after getting it...

Fauci predicts the COVID-19 pandemic likely won’t improve by Christmas or New Year’s Day

In a recent interview with USA Today, Dr. Anthony Fauci said that Americans should prepare themselves for a difficult holiday season. Fauci said that...

Covid-19 roundup: Inovio enlists plasmid manufacturer to replace the one it’s in legal feud with; Cyberattacks spotted targeting vaccine distribution  –

With its Phase II trial finally underway, Inovio has enlisted another key manufacturing partner to hit its goal of hundreds of millions of doses of its DNA vaccine — if it manages to force its old contract manufacturer into starting tech transfer. Japan’s Kaneka Eurogentec is tasked with plasmid production,

How Jonathan Van-Tam won the nation’s trust on coronavirus | Health policy | The Guardian

Wryly ebullient deputy chief medical officer now seems to be TV’s ‘scientist of choice’

UK approves Pfizer-BioNTech COVID-19 vaccine, first in the world | Reuters

Britain on Wednesday became the first western country to approve a COVID-19 vaccine, jumping ahead of the United States and Europe after its regulator cleared a shot developed by Pfizer for emergency use in record time.

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 | bioRxiv

bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution

Most adults over 50 say they’ll get a COVID vaccine

Most—but not all—older adults will get a COVID-19 vaccine once it's available. Many want to wait and see how others fare after getting it...

Quick Read

Covid-19 roundup: Inovio enlists plasmid manufacturer to replace the one it’s in legal feud with; Cyberattacks spotted targeting vaccine distribution  –

With its Phase II trial finally underway, Inovio has enlisted another key manufacturing partner to hit its goal of hundreds of millions of doses of its DNA vaccine — if it manages to force its old contract manufacturer into starting tech transfer. Japan’s Kaneka Eurogentec is tasked with plasmid production,

How Jonathan Van-Tam won the nation’s trust on coronavirus | Health policy | The Guardian

Wryly ebullient deputy chief medical officer now seems to be TV’s ‘scientist of choice’

UK approves Pfizer-BioNTech COVID-19 vaccine, first in the world | Reuters

Britain on Wednesday became the first western country to approve a COVID-19 vaccine, jumping ahead of the United States and Europe after its regulator cleared a shot developed by Pfizer for emergency use in record time.

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 | bioRxiv

bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution

Most adults over 50 say they’ll get a COVID vaccine

Most—but not all—older adults will get a COVID-19 vaccine once it's available. Many want to wait and see how others fare after getting it...

Fauci predicts the COVID-19 pandemic likely won’t improve by Christmas or New Year’s Day

In a recent interview with USA Today, Dr. Anthony Fauci said that Americans should prepare themselves for a difficult holiday season. Fauci said that...

Prevention Strategy

Covid-19 roundup: Inovio enlists plasmid manufacturer to replace the one it’s in legal feud with; Cyberattacks spotted targeting vaccine distribution  –

With its Phase II trial finally underway, Inovio has enlisted another key manufacturing partner to hit its goal of hundreds of millions of doses of its DNA vaccine — if it manages to force its old contract manufacturer into starting tech transfer. Japan’s Kaneka Eurogentec is tasked with plasmid production,

How Jonathan Van-Tam won the nation’s trust on coronavirus | Health policy | The Guardian

Wryly ebullient deputy chief medical officer now seems to be TV’s ‘scientist of choice’

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 | bioRxiv

bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution

Most adults over 50 say they’ll get a COVID vaccine

Most—but not all—older adults will get a COVID-19 vaccine once it's available. Many want to wait and see how others fare after getting it...

Global Impact

Covid-19 roundup: Inovio enlists plasmid manufacturer to replace the one it’s in legal feud with; Cyberattacks spotted targeting vaccine distribution  –

With its Phase II trial finally underway, Inovio has enlisted another key manufacturing partner to hit its goal of hundreds of millions of doses of its DNA vaccine — if it manages to force its old contract manufacturer into starting tech transfer. Japan’s Kaneka Eurogentec is tasked with plasmid production,

UK approves Pfizer-BioNTech COVID-19 vaccine, first in the world | Reuters

Britain on Wednesday became the first western country to approve a COVID-19 vaccine, jumping ahead of the United States and Europe after its regulator cleared a shot developed by Pfizer for emergency use in record time.

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 | bioRxiv

bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution

Fauci predicts the COVID-19 pandemic likely won’t improve by Christmas or New Year’s Day

In a recent interview with USA Today, Dr. Anthony Fauci said that Americans should prepare themselves for a difficult holiday season. Fauci said that...

Covid-19 roundup: Inovio enlists plasmid manufacturer to replace the one it’s in legal feud with; Cyberattacks spotted targeting vaccine distribution  –

With its Phase II trial finally underway, Inovio has enlisted another key manufacturing partner to hit its goal of hundreds of millions of doses of its DNA vaccine — if it manages to force its old contract manufacturer into starting tech transfer. Japan’s Kaneka Eurogentec is tasked with plasmid production,

How Jonathan Van-Tam won the nation’s trust on coronavirus | Health policy | The Guardian

Wryly ebullient deputy chief medical officer now seems to be TV’s ‘scientist of choice’

UK approves Pfizer-BioNTech COVID-19 vaccine, first in the world | Reuters

Britain on Wednesday became the first western country to approve a COVID-19 vaccine, jumping ahead of the United States and Europe after its regulator cleared a shot developed by Pfizer for emergency use in record time.

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 | bioRxiv

bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution

Most adults over 50 say they’ll get a COVID vaccine

Most—but not all—older adults will get a COVID-19 vaccine once it's available. Many want to wait and see how others fare after getting it...

Fauci predicts the COVID-19 pandemic likely won’t improve by Christmas or New Year’s Day

In a recent interview with USA Today, Dr. Anthony Fauci said that Americans should prepare themselves for a difficult holiday season. Fauci said that...

Video News

Latest Articles

Covid-19 roundup: Inovio enlists plasmid manufacturer to replace the one it’s in legal feud with; Cyberattacks spotted targeting vaccine distribution  –

With its Phase II trial finally underway, Inovio has enlisted another key manufacturing partner to hit its goal of hundreds of millions of doses of its DNA vaccine — if it manages to force its old contract manufacturer into starting tech transfer. Japan’s Kaneka Eurogentec is tasked with plasmid production,

How Jonathan Van-Tam won the nation’s trust on coronavirus | Health policy | The Guardian

Wryly ebullient deputy chief medical officer now seems to be TV’s ‘scientist of choice’

UK approves Pfizer-BioNTech COVID-19 vaccine, first in the world | Reuters

Britain on Wednesday became the first western country to approve a COVID-19 vaccine, jumping ahead of the United States and Europe after its regulator cleared a shot developed by Pfizer for emergency use in record time.

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 | bioRxiv

bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution

Most adults over 50 say they’ll get a COVID vaccine

Most—but not all—older adults will get a COVID-19 vaccine once it's available. Many want to wait and see how others fare after getting it...

Fauci predicts the COVID-19 pandemic likely won’t improve by Christmas or New Year’s Day

In a recent interview with USA Today, Dr. Anthony Fauci said that Americans should prepare themselves for a difficult holiday season. Fauci said that...

Covid-19 roundup: Inovio enlists plasmid manufacturer to replace the one it’s in legal feud with; Cyberattacks spotted targeting vaccine distribution  –

With its Phase II trial finally underway, Inovio has enlisted another key manufacturing partner to hit its goal of hundreds of millions of doses of its DNA vaccine — if it manages to force its old contract manufacturer into starting tech transfer. Japan’s Kaneka Eurogentec is tasked with plasmid production,

How Jonathan Van-Tam won the nation’s trust on coronavirus | Health policy | The Guardian

Wryly ebullient deputy chief medical officer now seems to be TV’s ‘scientist of choice’

UK approves Pfizer-BioNTech COVID-19 vaccine, first in the world | Reuters

Britain on Wednesday became the first western country to approve a COVID-19 vaccine, jumping ahead of the United States and Europe after its regulator cleared a shot developed by Pfizer for emergency use in record time.

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 | bioRxiv

bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution

Most adults over 50 say they’ll get a COVID vaccine

Most—but not all—older adults will get a COVID-19 vaccine once it's available. Many want to wait and see how others fare after getting it...

We have daily and weekly curated newsletters.

Just click above to choose your options.